Linnea Doyle is a strategic and results-driven leader in the pharmaceutical industry, currently serving as the Head of US Sales & Operations for HIV Prevention. With extensive experience at Roche, including positions such as Director of New Product Development and Business Unit Director for Breast Oncology, Linnea has a proven track record in sales, market access, and product launches. At Gilead Sciences, Linnea held the role of Executive Director for Global Commercial Product Strategy within the HIV franchise and led market access efforts during significant organizational growth. Linnea's ability to develop high-performing teams and optimize business and patient outcomes has been instrumental throughout their career. Linnea is pursuing a Bachelor of Arts in Political Science and English at Queen's University.
This person is not in any teams
This person is not in any offices